VERTEX PHARMACEUTICALS INCORPORATED H-1B Visa Sponsorship & Salary Data

The median H-1B salary at VERTEX PHARMACEUTICALS INCORPORATED is $119,496, based on 920 certified filings from FY 2020 to FY 2026. This is equal to the national H-1B median salary of $120,000. Compensation at VERTEX PHARMACEUTICALS INCORPORATED reflects their market positioning, with entry-level roles starting around $100,797 and senior positions reaching $161,500 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at VERTEX PHARMACEUTICALS INCORPORATED range from $81,016 at the 10th percentile to $161,500 at the 90th percentile, showing a $80,484 spread across experience levels and roles. The 25th percentile is $100,797 and the 75th percentile is $139,922.

Yes, VERTEX PHARMACEUTICALS INCORPORATED actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), VERTEX PHARMACEUTICALS INCORPORATED filed 145 H-1B labor condition applications with 139 certified and 0 denied, at a median salary of $132,200. Across FY 2020–2026, they have filed 949 total H-1B applications with 920 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. VERTEX PHARMACEUTICALS INCORPORATED sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), VERTEX PHARMACEUTICALS INCORPORATED filed 145 H-1B applications, with 139 certified and 0 denied. Over 7 years of data, VERTEX PHARMACEUTICALS INCORPORATED has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

VERTEX PHARMACEUTICALS INCORPORATED's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 949 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating VERTEX PHARMACEUTICALS INCORPORATED as a potential H-1B sponsor.

This is an excellent approval rate, indicating VERTEX PHARMACEUTICALS INCORPORATED has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

VERTEX PHARMACEUTICALS INCORPORATED sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 920 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles VERTEX PHARMACEUTICALS INCORPORATED most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at VERTEX PHARMACEUTICALS INCORPORATED:

The most frequently sponsored role is Research Scientist with 106 filings at a median salary of $108,737. This is followed by Senior Research Scientist (81 filings) and Senior Statistical Programmer II.

VERTEX PHARMACEUTICALS INCORPORATED's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where VERTEX PHARMACEUTICALS INCORPORATED sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top VERTEX PHARMACEUTICALS INCORPORATED H-1B locations:

The largest H-1B hub for VERTEX PHARMACEUTICALS INCORPORATED is Boston, MA with 718 filings at a median salary of $119,000. The highest-paying location is Apex, NC at $164,400 median. Salaries range from $67,413 to $164,400 across office locations.

VERTEX PHARMACEUTICALS INCORPORATED's median H-1B salary has increased by +38% from FY 2020 ($96,000) to FY 2026 ($132,200). Tracking salary trends over time reveals how VERTEX PHARMACEUTICALS INCORPORATED adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at VERTEX PHARMACEUTICALS INCORPORATED.

Year-by-year breakdown:

• FY 2022: $113,000 (158 certified)
• FY 2023: $124,896 (111 certified)
• FY 2024: $123,304 (144 certified)
• FY 2025: $133,850 (184 certified)
• FY 2026: $132,200 (139 certified)

This 38% growth reflects strong compensation adjustments at VERTEX PHARMACEUTICALS INCORPORATED, keeping pace with market demands for H-1B talent.

VERTEX PHARMACEUTICALS INCORPORATED primarily files H-1B applications at Wage Level IV, accounting for 43% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making VERTEX PHARMACEUTICALS INCORPORATED's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 91% of positions at Level II or higher, VERTEX PHARMACEUTICALS INCORPORATED typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

VERTEX PHARMACEUTICALS INCORPORATED's median H-1B salary of $119,496 is equal to the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating VERTEX PHARMACEUTICALS INCORPORATED's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare VERTEX PHARMACEUTICALS INCORPORATED's offerings with similar companies in your field for a more accurate assessment.

VERTEX PHARMACEUTICALS INCORPORATED's H-1B salaries are competitive with industry averages. The 920 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. VERTEX PHARMACEUTICALS INCORPORATED's higher proportion of Level III-IV positions (67%) may benefit from wage-based lottery prioritization.

With 920 certified filings, VERTEX PHARMACEUTICALS INCORPORATED invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.